Skip to main content
. 2019 Oct 9;60(6):707–715. doi: 10.1002/mus.26695

Figure 2.

Figure 2

Distribution of (A) MG‐ADL and (B) MG‐QOL15 at sign‐up. The majority of patients reported moderate to severe impairment in their activities of daily living, as measured by MG‐ADL (N = 1140) and MG‐QOL15 (N = 1138) scale scores. MG‐ADL, Myasthenia Gravis—Activities of Daily Living; MG‐QOL15, 15‐item Myasthenia Gravis Quality of Life